Solid Tumors

Therapy Areas

OncoNews

OncoNews

Lung Icon

Lung Cancer

Uterus Icon

Women's Cancers

Bladder Icon

Urogenital

GI Icon

Gastro-intestinal

Hematology Icon

Hematology

Other Solid Tumor Icon

Other Tumors

Videos

BRCA Session by Berna Özdemir
Nov 02 2022
Biomarkers

BRCA Mutated Tumors

} 1 h 31 min

watch now
SAKK's Post AACR 2022
May 05 2022
Solid Tumors

SAKK’s Post-AACR 2022

} 2 h 45 min

watch now
Melanoma Session by Olivier Michielin
Jun 16 2021
Solid Tumors

Melanoma

} 1 h 03 min

watch now

Articles

Swiss Approval
OncoNews
Jun 24 2024
Urogenital
Recent Advances in Cancer Treatment: New Approvals in Prostate, Solid Tumors, and Colorectal Cancer
FDA Approval
Jun 14 2024
Solid Tumors
FDA Approves Repotrectinib for Patients with NTRK Gene Fusion-Positive Solid Tumors
FDA Approval
Thyroid Cancer
Jun 13 2024
Solid Tumors
FDA Approves Selpercatinib for RET Fusion-Positive Thyroid Cancer
EMA Approval
Lung Cancer
Jun 07 2024
Lung Cancer
Recent Drug Approvals Transforming Oncology Care

UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

MPN

Gabriela Baerlocher

Hirslanden Clinic Zurich, Switzerland

Claire Harrison

Guy's and St. Thomas' NHS Foundation Trust, London, UK

Sara Meyer

Inselspital, University Hospital Bern, Switzerland

AGENDA

Managing PV and MF: Integrating interferons, immunotherapies and new JAK2 inhibitors

Sara Meyer

Clinical significance of genomic testing in MPN: When to test what and what does it really mean?

TBD

Update on the management of CML: Navigating through the available and upcoming treatment options

Gabriela Baerlocher

2 CME Points by

SWISS SOCIETY OF HEMATOLOGY
(SGH • SSH)

Join our host, Sara Meyer, for an insightful roundtable on the latest progress in the treatment of myeloproliferative neoplasms (MPNs). This interdisciplinary roundtable gathers renowned experts to discuss groundbreaking findings, offering an in-depth exploration of new innovative therapeutic approaches for myelofibrosis, polycythaemia vera and chronic myeloid leukemia. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the treatment landscape of myeloproliferative neoplasms.

ADD THIS TO YOUR CALENDAR

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.

First Time On OncoViews?

Get Registered Now